PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer

PDG 将干细胞生态位与胰腺上皮更新、修复和癌症联系起来

基本信息

  • 批准号:
    9276626
  • 负责人:
  • 金额:
    $ 31.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-01 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Stem cell niches are responsible for life-long renewal of most epithelial surfaces throughout the body. Dysregulation of these cells is believed to result in metaplasia and cancer. To date little is known about these somatic stem cell niches or their contribution to pancreatic epithelial regeneration and cancer. Our laboratory has recently discovered a novel epithelial stem cell compartment, Pancreatic Duct Glands (PDG). These glands uniquely express Shh and TFF2 as well as other developmental genes known to reside in progenitor stem cell niches. In response to acute injury these glands are capable of asymmetric division that gives rise to differentiated daughter cells which then migrate to repopulate the main ducts. In response to chronic inflammation these cells can undergo a GI metaplasia and cystic hypertrophy which histologically and molecularly resemble side-branch IPMN, known precursors of PDAC. Evaluation of human IPMN reveals that PDG form the proliferative basilar crypt segment of these large papillary projections. This proposal is focused on characterizing the role of the PDG compartment in epithelial regeneration and carcinogenesis. [SA1] The experiments proposed in this aim will determine the role of PDG as an epithelial progenitor stem cell niche responsible for epithelial renewal and regeneration. We propose to use a fate mapping, in vivo lineage tagging strategy specifically tagging the PDG compartment, in combination with a well-characterized model of acute and chronic pancreatic injury, to confirm that these compartments contain epithelial progenitor cells. In vitro and in viv strategies are also proposed to determine if these cells have multipotential capacity. Our preliminary data suggests that this compartment has at least two populations of stem cells, label retaining cells (LRC) and transient amplifying cells (TA). In order to better characterize this two stem cell population we propose a developmental sub-aim to evaluate the transcriptome by mRNA-Seq from minimal (10-cell) samples in order to identify unique markers for these cells, as well as understand key pathways that regulate this compartment during regeneration and inflammatory metaplasia. [SA2] To determine the mechanisms by which PDG contribute to the formation of pancreatic cancer precursor lesions, side-branch IPMN and cancer. To accomplish this aim we propose to use in an in vivo lineage tagging and PDG cell-specific oncogene activation strategy in mice to identify PDG as the compartment of origin for IPMN and invasive cancer. Further insight into the mechanisms underlying the formation of precursor lesions will be gained in human and mouse specimens by using a mitochondrial mutational mapping strategy to show that IPMN are formed by niche succession, monoclonal conversion and gland fission. mRNA SMART- Seq of low, moderate and high grade dysplastic IPMN may allow us to understand key pathways involved in initiation, progression, and invasion. Understanding how this compartment contributes to regeneration and cancer will give us new insights into cancer prevention, early diagnosis and treatment.
描述(由申请人提供):干细胞龛负责整个身体大多数上皮表面的终身更新。这些细胞的失调被认为是结果

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SARAH P THAYER其他文献

SARAH P THAYER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SARAH P THAYER', 18)}}的其他基金

Core 3: Histology and Tissue Core
核心 3:组织学和组织核心
  • 批准号:
    10413943
  • 财政年份:
    2018
  • 资助金额:
    $ 31.23万
  • 项目类别:
Core 3: Histology and Tissue Core
核心 3:组织学和组织核心
  • 批准号:
    10203867
  • 财政年份:
    2018
  • 资助金额:
    $ 31.23万
  • 项目类别:
PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer
PDG 将干细胞生态位与胰腺上皮更新、修复和癌症联系起来
  • 批准号:
    8706833
  • 财政年份:
    2013
  • 资助金额:
    $ 31.23万
  • 项目类别:
PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer
PDG 将干细胞生态位与胰腺上皮更新、修复和癌症联系起来
  • 批准号:
    8577922
  • 财政年份:
    2013
  • 资助金额:
    $ 31.23万
  • 项目类别:
PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer
PDG 将干细胞生态位与胰腺上皮更新、修复和癌症联系起来
  • 批准号:
    9069776
  • 财政年份:
    2013
  • 资助金额:
    $ 31.23万
  • 项目类别:
BIOBANK CORE
生物样本库核心
  • 批准号:
    8052123
  • 财政年份:
    2011
  • 资助金额:
    $ 31.23万
  • 项目类别:
Core C: Biobank Core
核心 C:生物样本库核心
  • 批准号:
    7037893
  • 财政年份:
    2005
  • 资助金额:
    $ 31.23万
  • 项目类别:
The Hedgehog Pathway and Pancreatic Neoplasia
Hedgehog通路和胰腺肿瘤
  • 批准号:
    6947879
  • 财政年份:
    2004
  • 资助金额:
    $ 31.23万
  • 项目类别:
The Hedgehog Pathway and Pancreatic Neoplasia
Hedgehog通路和胰腺肿瘤
  • 批准号:
    7273561
  • 财政年份:
    2004
  • 资助金额:
    $ 31.23万
  • 项目类别:
The Hedgehog Pathway and Pancreatic Neoplasia
Hedgehog通路和胰腺肿瘤
  • 批准号:
    6812673
  • 财政年份:
    2004
  • 资助金额:
    $ 31.23万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了